Europe Biotechnology Reagents & Kits Market Size & Outlook
Europe biotechnology reagents & kits market, 2018-2028 (US$B)
Related Markets
Europe biotechnology reagents & kits market highlights
- The Europe biotechnology reagents & kits market generated a revenue of USD 98.6 billion in 2020.
- The market is expected to grow at a CAGR of 15.8% from 2021 to 2028.
- In terms of segment, detection kits was the largest revenue generating kit type in 2020.
- Detection Kits is the most lucrative kit type segment registering the fastest growth during the forecast period.
- Country-wise, Spain is expected to register the highest CAGR from 2021 to 2028.
Europe data book summary
| Market revenue in 2020 | USD 98.6 billion |
| Market revenue in 2028 | USD 318.5 billion |
| Growth rate | 15.8% (CAGR from 2020 to 2028) |
| Largest segment | Detection kits |
| Fastest growing segment | Detection Kits |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD billion |
| Market segmentation | Purification Kits, Amplification Kits, Detection Kits, Isolation Kits |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.2% of the global biotechnology reagents & kits market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 355.3 billion by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biotechnology Reagents & Kits Market Scope
Biotechnology Reagents & Kits Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe biotechnology reagents & kits market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology reagents & kits market will help companies and investors design strategic landscapes.
Detection kits was the largest segment with a revenue share of 22.92% in 2020. Horizon Databook has segmented the Europe biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
The European market holds a substantial share in biotechnology reagents and kits market. Wide applications of reagents and kits drive regional market growth. Reagent plays an important role in diagnosis of diseases and helps in drug discovery & several biotech research programs.
Hence, it is used in many pharmaceuticals as well as biotechnology companies. Several key players in the market provide products under reagents & kits. Various companies are taking strategic initiatives to fulfill the growing market demand.
The reagents magnetic bead based, automated method retrieves & isolates virus particles and their corresponding RNA on various sensitive stands, for subsequent RT-PCR analysis. In addition, in September 2020, QIAGEN acquired NeuMoDx Molecular, Inc, a diagnostics instruments company.
Reasons to subscribe to Europe biotechnology reagents & kits market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe biotechnology reagents & kits market databook
-
Our clientele includes a mix of biotechnology reagents & kits market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biotechnology reagents & kits market , including forecasts for subscribers. This continent databook contains high-level insights into Europe biotechnology reagents & kits market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Europe biotechnology reagents & kits market size, by country, 2018-2028 (US$B)
Europe Biotechnology Reagents & Kits Market Outlook Share, 2020 & 2028 (US$B)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
